VALIANTORG

Valiant Organics Limited

Specialty chemicals and pharma products manufacturer

Commodities›Chemicals›Chemicals & Petrochemicals›Specialty Chemicals

Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹468.55
Market cap
1,314 Cr
Stock P/E
24.3
P/B
1.73
Dividend yield
0.9%
ROE (FY26)
4.4%
ROCE (FY26)
5.9%
Operating margin (FY26)
6.6%
Debt / equity (FY26)
0.33
OCF / EBITDA (FY26)
104.3%
OCF / EBITDA (3Y)
129.0%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

Valiant Organics makes specialty chemicals (chlorination, hydrogenation and ammonolysis products) and pharma intermediates, sold to the industries it serves.

Company snapshot

40thBy market cap

Ranked among 68 companies in Specialty Chemicals.

What we see

Positives
  • ✓129% of operating profit came in as cash over the last three years — profits are backed by real cash.

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales203 Cr141 Cr177 Cr168 Cr160 Cr187 Cr204 Cr204 Cr157 Cr159 Cr218 Cr232 Cr
Operating expenses (approx.)188 Cr138 Cr179 Cr152 Cr158 Cr172 Cr184 Cr180 Cr136 Cr144 Cr191 Cr190 Cr
EBITDA15 Cr4 Cr-2 Cr16 Cr2 Cr15 Cr20 Cr25 Cr21 Cr16 Cr26 Cr42 Cr
OPM %7.6%2.7%-1.0%9.4%1.5%8.2%10.0%12.1%13.4%9.8%12.2%18.0%
Other income4 Cr0.40 Cr2 Cr0.38 Cr3 Cr5 Cr0.68 Cr1 Cr0.20 Cr2 Cr4 Cr3 Cr
Interest4 Cr4 Cr7 Cr5 Cr8 Cr6 Cr5 Cr6 Cr4 Cr5 Cr3 Cr5 Cr
Depreciation9 Cr9 Cr9 Cr9 Cr9 Cr9 Cr9 Cr9 Cr10 Cr10 Cr10 Cr10 Cr
Profit before tax6 Cr-10 Cr-25 Cr2 Cr-14 Cr6 Cr7 Cr11 Cr7 Cr6 Cr18 Cr37 Cr
Tax %25.9%19.5%19.7%118.5%9.4%16.1%42.8%26.2%23.8%37.7%10.4%20.4%
Net profit5 Cr-8 Cr-20 Cr-0.62 Cr-12 Cr5 Cr4 Cr8 Cr6 Cr4 Cr16 Cr29 Cr
EPS (₹)₹1.58₹-2.90₹-3.90₹-0.23₹-4.52₹1.08₹1.52₹2.93₹2.02₹1.30₹5.61₹10.44

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales692 Cr675 Cr755 Cr1,153 Cr1,052 Cr723 Cr719 Cr739 CrSign in free for the trailing twelve months
Operating expenses (approx.)512 Cr496 Cr550 Cr948 Cr888 Cr685 Cr665 Cr651 CrSign in free for the trailing twelve months
EBITDA180 Cr179 Cr205 Cr205 Cr164 Cr38 Cr54 Cr88 CrSign in free for the trailing twelve months
OPM %26.0%26.5%27.2%17.8%15.6%5.3%7.5%11.9%Sign in free for the trailing twelve months
Other income9 Cr21 Cr6 Cr7 Cr8 Cr9 Cr9 Cr7 CrSign in free for the trailing twelve months
Interest4 Cr2 Cr5 Cr6 Cr11 Cr16 Cr24 Cr18 CrSign in free for the trailing twelve months
Depreciation14 Cr15 Cr21 Cr30 Cr29 Cr35 Cr36 Cr40 CrSign in free for the trailing twelve months
Profit before tax171 Cr183 Cr185 Cr176 Cr137 Cr-9 Cr2 Cr42 CrSign in free for the trailing twelve months
Tax %29.2%23.1%29.2%27.4%25.2%3.4%259.3%20.8%Sign in free for the trailing twelve months
Net profit133 Cr139 Cr131 Cr128 Cr103 Cr-8 Cr-3 Cr33 CrSign in free for the trailing twelve months
EPS (₹)₹99.82₹114.02₹44.68₹41.72₹32.45₹-3.07₹-1.24₹11.86Sign in free for the trailing twelve months
Dividend payout %——5.2%0.0%11.9%——0.0%Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital59 Cr12 Cr27 Cr28 Cr28 Cr28 Cr28 Cr28 Cr
Reserves245 Cr357 Cr481 Cr586 Cr662 Cr702 Cr697 Cr731 Cr
Borrowings——186 Cr363 Cr274 Cr256 Cr248 Cr253 Cr
Other liabilities145 Cr283 Cr182 Cr173 Cr226 Cr262 Cr209 Cr219 Cr
Total liabilities448 Cr652 Cr876 Cr1,185 Cr1,239 Cr1,248 Cr1,183 Cr1,231 Cr
Fixed assets (net)215 Cr405 Cr497 Cr531 Cr658 Cr630 Cr644 Cr682 Cr
CWIP——46 Cr112 Cr71 Cr86 Cr66 Cr21 Cr
Investments12 Cr5 Cr6 Cr8 Cr41 Cr99 Cr94 Cr151 Cr
Loans & advances——0.69 Cr0.81 Cr0.78 Cr49 Cr49 Cr0.66 Cr
Inventories48 Cr45 Cr72 Cr114 Cr126 Cr114 Cr89 Cr92 Cr
Trade receivables141 Cr133 Cr157 Cr321 Cr254 Cr209 Cr177 Cr243 Cr
Cash & bank4 Cr13 Cr13 Cr25 Cr8 Cr3 Cr7 Cr2 Cr
Other assets28 Cr52 Cr84 Cr74 Cr80 Cr57 Cr57 Cr40 Cr
Total assets448 Cr652 Cr876 Cr1,185 Cr1,239 Cr1,248 Cr1,183 Cr1,231 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity—161 Cr113 Cr-32 Cr238 Cr84 Cr56 Cr92 Cr
Cash from investing—-179 Cr-156 Cr-122 Cr-143 Cr-65 Cr-21 Cr-86 Cr
Cash from financing—27 Cr49 Cr167 Cr-112 Cr-23 Cr-32 Cr-11 Cr
Net cash flow—9 Cr5 Cr12 Cr-17 Cr-4 Cr4 Cr-5 Cr
Free cash flow (OCF − Capex)——113 Cr-153 Cr102 Cr10 Cr26 Cr58 Cr

Ratios

MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %57.6%50.1%27.3%18.0%14.6%0.8%2.6%5.9%
ROE %43.9%37.5%22.5%17.5%11.9%-1.2%-0.5%4.4%
Debtor days7472761018810690120
Inventory days4243645368867475
Days payable——945889157123101
Cash conversion cycle116114459767354095
OCF / EBITDA %—90.0%55.0%-15.9%144.9%219.6%105.1%104.3%
OCF / EBITDA % (3 years)———41.0%55.4%71.1%147.7%129.0%
Debt / equity0.000.000.370.590.400.350.340.33
Current ratio1.861.341.121.291.201.000.971.01
Net debt / EBITDA-0.02-0.070.841.651.626.614.502.85